Reproductive hormones have been demonstrated to modulate both gap-and tight-junction protein expression in 19 reproductive tissues and endometrium, however the effects of changes in reproductive hormones on the selective 20 permeability of the blood-brain barrier (BBB) remain unclear. 
Introduction

57
The blood-brain barrier (BBB) maintains brain homeostasis by 58 limiting entry of substances to the central nervous system [1] through 59 interaction of transmembrane and intracellular proteins that make up 60 endothelial cell tight junctions and gap junctions. Although complex, 61 tight-junction proteins such as zona occludens 1 (ZO-1) and ZO-2, 62 occludin and claudin-5, and gap-junction proteins such as connexin-samples were then centrifuged at 1500 g for 10 min and the supernatant was analyzed 158 at 620 nm using a spectrophotometer. Results were calculated as µM of Evan's blue dye 159 per hemisphere as compared to a standard Evans blue dye curve. The other hemisphere 160 of tissue was processed for histological analysis (as described below). Table 1 summarizes the experimental design and predicted effects of each treat-166 ment on blood hormone levels. In the ovariectomized vehicle group, blood LH and FSH 167 levels become elevated while estrogen levels decline; in the ovariectomized plus 168 leuprolide-treated group, blood LH, FSH and estrogen levels all decline. This experimental 169 design differentiates between whether end-point changes are due to LH/FSH or sex steroids.
170
GnRH agonist treatment
171
Leuprolide acetate, a well-known gonadotropin-releasing hormone (GnRH) agonist
172
(Lupron Depot, TAP Pharmaceuticals Inc., Lake Forest) was used for the experiments.
173
Leuprolide acetate is a synthetic GnRH agonist that lowers LH/FSH levels by de- 
Tissue collection
185
Blood was collected from B6/SJL mice pre-treatment and at 14 days post-surgery 186 from an orbital sinus after mice were anesthetized with an IP injection of mouse 187 anesthesia cocktail (0.1 ml/25 g containing ketamine HC1 15 mg (100 mg/ml) 0.15 ml; 188 xylazine HC1 3 mg (20 mg/ml) 0.15 ml; acepromazine 0.5 mg (10 mg/ml) 0.05 ml; and 189 sterile saline 1.4 ml). Blood was collected from Tg2576 mice at~7.5 months of age and 190 then again at the end of the 1st and 3rd months from an orbital sinus after mice were 191 anesthetized as above. The final blood at 9 months was collected by heart puncture.
192
Blood was collected from animals prior to their next dose of leuprolide acetate. Blood
193
(100-400 µl) was collected into EDTA-coated tubes, which were centrifuged at 1000 g 194 for 3 min at 4°C, followed by centrifugation at 5000 g for 10 min prior to the collection 195 of plasma, which was stored at −80°C. Mice were sacrificed at 16 months of age with an 196 injection of concentrated sodium barbital (50 µl each, 392 mg/ml, IP). Blood was col-197 lected at this time by heart puncture, the animals were then perfused with phosphate 198 buffered saline (PBS; Gibco, pH 7.4), the animals decapitated and the brain removed Fig. 1 . Quantitation of Evan's blue extravasation. Female B6/SJL mice were either ovariectomized (n = 5) or left intact (n = 5). Two weeks after surgery mice were injected with a 2% Evan's blue dye solution to examine BBB permeability. There was a 2.2-fold increase in Evan's blue dye extravasation into the brains of ovariectomized female mice compared to control (mean ± SEM, P b 0.05). 
Results
254
To assess the role of reproductive hormones in the maintenance of (0.44 ± 0.11 ng/ml vs 0.96 ± 0.07 ng/ml, respectively; P b 0.05; n = 9). 2.17 ng/ml vs 12.9 ± 2.18 ng/ml; n = 6). Ovariectomy induced a signi-300 ficant 10.9-fold increase in the concentration of plasma FSH from 4.8 ± and controls using immunofluorescence (Fig. 4) 961 Da, the molecular mass of Evan's blue dye, to cross the BBB (Fig. 1 ).
342
At the molecular level, we observed no change in the expression of the 343 tight-junction protein ZO-1 (Figs. 4 and 5 ability precedes senile plaque formation in an Alzheimer disease model,
